On June 29, 3SBio rose 5.66% in regular trading, trading at 16.94 HKD/share, with turnover of approximately HKD 216 million.

On the news front, the company conducted intensive share buybacks over three consecutive trading days on June 22, 25, and 26, repurchasing a total of approximately 8.52 million shares at a cumulative cost of around HKD 135 million, with buyback prices ranging from HKD 15.40 to HKD 16.01. Additionally, Chairman Lou Jing purchased 516,000 shares on June 8 at approximately HKD 15.25 per share, while Huatai-PineBridge Fund increased its position by 636,500 shares on June 10 at approximately HKD 16.28 per share, bringing its stake to 7%.

The broader biotechnology sector rallied in tandem, with AKESO up 8.22%, INNOVENT BIO up 5.72%, SKB BIO up 5.26%, TRANSTHERA-B up 34.4%, and BEIGENE up 3.62%, reflecting strong sector-wide momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)